Day: January 5, 2023

26 posts

CES 2023: Jackery Reveals the Revolutionary New Portable Solar Generators, Leading the Solar Power Generation Industry

LAS VEGAS, Jan. 5, 2023 /PRNewswire/ — Jackery, the global leader of innovative portable power and green outdoor energy solutions, has unveiled  its most innovative portable solar generators to complement the high-end Pro family – the 3000 Pro and 1500 Pro – at CES 2023 (booth No.8943), running from January 5-8, 2023 in Las Vegas. […]

Duck Creek to acquire Imburse Payments, a modern payments platform

Strategic acquisition will add digital, out-of-the box payments capabilities to Duck Creek’s comprehensive suite of SaaS solutions for P&C and general insurers Boston, MA, Jan. 05, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT) (“Duck Creek”), the intelligent solutions provider defining the future of property and casualty (P&C) insurance, today announced a definitive agreement […]

iHerb Top Wellness Trends in 2023

Dr. Michael Murray, N.D. forecasts the 2023 wellness trends on the rise on iHerb’s popular blog PASADENA, Calif., Jan. 5, 2023 /PRNewswire/ — iHerb, the largest eCommerce platform, dedicated to vitamins, minerals, and supplements has tapped Dr. Michael Murray, N.D. – one of the leading authorities in dietary supplements, and natural products – to share his […]

‫نادين شكر رئيسة تنفيذية لشركة Securrency الرائدة في مجال الابتكار في التكنولوجيا المالية

شكر ستقود المرحلة التالية من النموّ مع تسريع  Securrency تسويق تكنولوجيا الأصول الرقمية القائمة على الامتثال للمؤسسات المالية الدولية واشنطن، 5 يناير 2023 / PRNewswire / – أعلنت اليوم شركة Securrency الرائدة في مجال تطوير التكنولوجيا المالية والتنظيمية القائمة على البلوك تشين عن انضمام نادين شكر إلى الشركة بمنصب الرئيسة التنفيذية اعتبارًا من 9 يناير 2023. وتتمتّع السيدة […]

AUM Biosciences Receives U.S. FDA Rare Pediatric Disease Designation for AUM302 for Treatment of Neuroblastoma

AUM302 is potentially eligible to receive a rare pediatric disease priority review voucher at the time of marketing approval SINGAPORE and BETHESDA, Md., Jan. 05, 2023 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a global clinical-stage biotech company focused on discovering and developing precision oncology therapeutics, announced today that the U.S. Food and Drug […]